TRAX
First Tracks Biotherapeutics
NASDAQ: TRAX · HEALTHCARE · BIOTECHNOLOGY
$18.43
-10.78% today
Updated 2026-06-02
Market cap
$615.50M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.71
Dividend yield
—
52W range
$11 – $27
Volume
0.5M
First Tracks Biotherapeutics (TRAX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
—
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
When is the next earnings report?
Reporting date
March 31, 2026
Consensus EPS estimate
$-0.55
Fiscal period ending
2026-03-31
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.55 | — | — | — | — |
Frequently asked questions
When does First Tracks Biotherapeutics report next earnings?
First Tracks Biotherapeutics (TRAX) is scheduled to report earnings on March 31, 2026. The consensus EPS estimate is $-0.55.